Cargando…
PGC‐1α inhibits polyamine metabolism in Cyclin E1‐driven ovarian cancer
AIM: Cyclin E1‐driven ovarian cancer (OvCa) is characterized with metabolic shift. In this study, we aim to pinpoint the metabolic pathway altered and assess its therapeutic potential. METHODS: In silico reproduction of TCGA ovarian cancer dataset and functional annotation using GSEA was performed....
Autores principales: | Guo, Ting, Li, Bin, Gu, Chao, Chen, Xiuying, Han, Mengxin, Liu, Xiaocheng, Xu, Congjian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912055/ https://www.ncbi.nlm.nih.gov/pubmed/31657115 http://dx.doi.org/10.1002/cam4.2637 |
Ejemplares similares
-
GCN-5/PGC-1α signaling is activated and associated with metabolism in cyclin E1-driven ovarian cancer
por: Guo, Ting, et al.
Publicado: (2019) -
HIF‐1α binding to AEG‐1 promoter induced upregulated AEG‐1 expression associated with metastasis in ovarian cancer
por: Zhao, Ting, et al.
Publicado: (2017) -
CCNG1 (Cyclin G1) regulation by mutant‐P53 via induction of Notch3 expression promotes high‐grade serous ovarian cancer (HGSOC) tumorigenesis and progression
por: Xu, Ying, et al.
Publicado: (2018) -
Epigenetically altered miR-193b targets cyclin D1 in prostate cancer
por: Kaukoniemi, Kirsi M, et al.
Publicado: (2015) -
COLGALT2 is overexpressed in ovarian cancer and interacts with PLOD3
por: Guo, Ting, et al.
Publicado: (2021)